Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LUMOS PHARMA, INC. | Chief Executive Officer, Director | Common Stock | 753K | $2.14M | $2.84 | Apr 1, 2024 | Direct |
Savara Inc | Director | Common Stock | 35.2K | $157K | $4.45 | Dec 14, 2023 | Direct |
PLUS THERAPEUTICS, INC. | Director | Common Stock | 15.2K | $22.8K | $1.50 | Sep 13, 2024 | Direct |
LUMOS PHARMA, INC. | Chief Executive Officer, Director | Common Stock | 4.47K | $12.7K | $2.84 | Apr 1, 2024 | By Charitable Trust |
LUMOS PHARMA, INC. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 35.4K | Apr 1, 2024 | Direct | ||
PLUS THERAPEUTICS, INC. | Director | Warrants (Right to buy) | 9.8K | May 8, 2024 | Direct | ||
PLUS THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 3.65K | Sep 11, 2024 | Direct | ||
Savara Inc | Director | Stock Option (Right to Buy) | 0 | Dec 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PSTV | PLUS THERAPEUTICS, INC. | Sep 13, 2024 | 1 | $6K | 4 | Sep 17, 2024 | Director |
PSTV | PLUS THERAPEUTICS, INC. | Sep 12, 2024 | 1 | $8.51K | 4 | Sep 16, 2024 | Director |
PSTV | PLUS THERAPEUTICS, INC. | Sep 11, 2024 | 1 | $0 | 4 | Sep 12, 2024 | Director |
PSTV | PLUS THERAPEUTICS, INC. | May 8, 2024 | 2 | $10K | 4 | May 10, 2024 | Director |
(LUMO) | LUMOS PHARMA, INC. | Apr 1, 2024 | 3 | $8.46K | 4 | Apr 3, 2024 | Chief Executive Officer, Director |
PSTV | PLUS THERAPEUTICS, INC. | Feb 22, 2024 | 1 | $0 | 4 | Feb 26, 2024 | Director |
(LUMO) | LUMOS PHARMA, INC. | Feb 1, 2024 | 1 | -$2.08K | 4 | Feb 5, 2024 | Chief Executive Officer, Director |
SVRA | Savara Inc | Dec 15, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Director |
SVRA | Savara Inc | Dec 11, 2023 | 2 | $8.89K | 4 | Dec 12, 2023 | Director |
LUMO | LUMOS PHARMA, INC. | Apr 1, 2023 | 1 | -$5.04K | 4 | Apr 4, 2023 | Chief Executive Officer, Director |
PSTV | PLUS THERAPEUTICS, INC. | Mar 3, 2023 | 1 | $1K | 4 | Mar 6, 2023 | Director |
PSTV | PLUS THERAPEUTICS, INC. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Director |
LUMO | LUMOS PHARMA, INC. | Feb 1, 2023 | 3 | $14.4K | 4 | Feb 3, 2023 | Chief Executive Officer, Director |
SVRA | Savara Inc | Dec 13, 2022 | 1 | $0 | 4 | Dec 15, 2022 | Director |
SVRA | Savara Inc | Dec 7, 2022 | 2 | $762 | 4 | Dec 8, 2022 | Director |
LUMO | LUMOS PHARMA, INC. | Sep 21, 2022 | 2 | $21.4K | 4 | Sep 23, 2022 | Chief Executive Officer, Director |
LUMO | LUMOS PHARMA, INC. | Sep 19, 2022 | 2 | $17.9K | 4 | Sep 21, 2022 | Chief Executive Officer, Director |
LUMO | LUMOS PHARMA, INC. | Apr 1, 2022 | 1 | -$13.5K | 4 | Apr 5, 2022 | Chief Executive Officer, Director |
LUMO | LUMOS PHARMA, INC. | Feb 1, 2022 | 3 | $43.4K | 4 | Feb 3, 2022 | Chief Executive Officer, Director |
SVRA | Savara Inc | Dec 13, 2021 | 3 | $400 | 4 | Dec 14, 2021 | Director |
PSTV | PLUS THERAPEUTICS, INC. | Jun 11, 2021 | 2 | $0 | 4 | Jun 11, 2021 | Director |